BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now
Advanced Search

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

7 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Small-molecule ligands of methyl-lysine binding proteins: optimization of selectivity for L3MBTL3.EBI
University of North Carolina At Chapel Hill
Identification of non-peptide malignant brain tumor (MBT) repeat antagonists by virtual screening of commercially available compounds.EBI
University of North Carolina At Chapel Hill
Small-molecule ligands of methyl-lysine binding proteins.EBI
University of North Carolina At Chapel Hill
Current advances of small molecule E3 ligands for proteolysis-targeting chimeras design.EBI
East China Normal University
Discovery of a Potent and Selective Fragment-like Inhibitor of Methyllysine Reader Protein Spindlin 1 (SPIN1).EBI
Icahn School of Medicine At Mount Sinai
The structure-activity relationships of L3MBTL3 inhibitors: flexibility of the dimer interface.EBI
University of North Carolina
In vitro and in vivo pharmacological characterization of N6-cyclopentyl-9-methyladenine (N-0840): a selective, orally active A1 adenosine receptor antagonist.BDB
Whitby Research